Personalis Inc (PSNL)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2025-01-30 | 2025-01-28 | V Vente |
CFO AND COO Dirigeant |
708
-0.4%
5,794 099 USD |
708 -0.4% | 5,79 | 4 099 USD | |
| 2025-01-30 | 2025-01-28 | V Vente |
CHIEF MEDICAL OFFICER AND EVP Dirigeant |
519
-0.4%
5,793 005 USD |
519 -0.4% | 5,79 | 3 005 USD | |
| 2024-12-18 | 2024-12-16 | V Vente |
CHIEF MEDICAL OFFICER AND EVP Dirigeant |
4 834
-3.8%
3,8218 466 USD |
4 834 -3.8% | 3,82 | 18 466 USD | |
| 2024-12-18 | 2024-12-16 | V Vente |
SVP and Chief Legal Officer Dirigeant |
1 513
-2.2%
3,825 780 USD |
1 513 -2.2% | 3,82 | 5 780 USD | |
| 2024-12-18 | 2024-12-16 | V Vente |
CFO AND COO Dirigeant |
6 865
-3.9%
3,8226 224 USD |
6 865 -3.9% | 3,82 | 26 224 USD | |
| 2024-11-20 | 2024-11-18 | V Vente |
SVP and Chief Legal Officer Dirigeant |
1 693
-2.5%
3,796 416 USD |
1 693 -2.5% | 3,79 | 6 416 USD | |
| 2024-11-20 | 2024-11-18 | VP Vente planifiée |
CHIEF MEDICAL OFFICER AND EVP Dirigeant |
921
-0.7%
3,793 491 USD |
921 -0.7% | 3,79 | 3 491 USD | |
| 2024-11-20 | 2024-11-18 | V Vente |
CFO AND COO Dirigeant |
1 307
-0.7%
3,794 954 USD |
1 307 -0.7% | 3,79 | 4 954 USD | |
| 2024-11-05 | 2024-11-01 | V Vente |
PRESIDENT AND CEO Administrateur exécutif |
26 443
-12.9%
5,38142 263 USD |
26 443 -12.9% | 5,38 | 142 263 USD | |
| 2024-08-20 | 2024-08-16 | A Achat | Actionnaire important |
3 500 000
+38.0%
5,0717 745 000 USD |
3 500 000 +38.0% | 5,07 | 17 745 000 USD | |
| 2024-08-01 | 2024-07-30 | V Vente |
CHIEF MEDICAL OFFICER AND EVP Dirigeant |
524
-0.4%
2,971 556 USD |
524 -0.4% | 2,97 | 1 556 USD | |
| 2024-08-01 | 2024-07-30 | V Vente |
CFO AND COO Dirigeant |
742
-0.4%
2,972 204 USD |
742 -0.4% | 2,97 | 2 204 USD | |
| 2024-06-20 | 2024-06-17 | V Vente |
SVP and Chief Legal Officer Dirigeant |
1 585
-2.2%
1,292 045 USD |
1 585 -2.2% | 1,29 | 2 045 USD | |
| 2024-06-20 | 2024-06-17 | V Vente |
CHIEF MEDICAL OFFICER AND EVP Dirigeant |
5 055
-3.8%
1,296 521 USD |
5 055 -3.8% | 1,29 | 6 521 USD | |
| 2024-06-20 | 2024-06-17 | V Vente |
CFO AND COO Dirigeant |
7 176
-3.9%
1,299 257 USD |
7 176 -3.9% | 1,29 | 9 257 USD | |
| 2024-05-21 | 2024-05-17 | V Vente |
CFO AND COO Dirigeant |
1 333
-0.7%
1,381 840 USD |
1 333 -0.7% | 1,38 | 1 840 USD | |
| 2024-05-21 | 2024-05-17 | VP Vente planifiée |
CHIEF MEDICAL OFFICER AND EVP Dirigeant |
940
-0.7%
1,381 297 USD |
940 -0.7% | 1,38 | 1 297 USD | |
| 2024-05-21 | 2024-05-17 | V Vente |
SVP and Chief Legal Officer Dirigeant |
1 731
-2.4%
1,382 389 USD |
1 731 -2.4% | 1,38 | 2 389 USD | |
| 2024-05-21 | 2024-05-17 | V Vente |
SVP and Chief Legal Officer Dirigeant |
1 731
-2.4%
1,382 389 USD |
1 731 -2.4% | 1,38 | 2 389 USD | |
| 2024-05-02 | 2024-04-30 | V Vente |
SVP and Chief Legal Officer Dirigeant |
4 523
-5.9%
1,376 197 USD |
4 523 -5.9% | 1,37 | 6 197 USD | |
| 2024-03-05 | 2024-03-01 | A Achat | Administrateur non-exécutif |
10 000
+62.1%
1,6716 700 USD |
10 000 +62.1% | 1,67 | 16 700 USD | |
| 2024-01-31 | 2024-01-29 | V Vente |
CHIEF MEDICAL OFFICER AND EVP Dirigeant |
526
-0.4%
1,37721 USD |
526 -0.4% | 1,37 | 721 USD | |
| 2024-01-31 | 2024-01-29 | V Vente |
CFO AND COO Dirigeant |
716
-0.4%
1,37981 USD |
716 -0.4% | 1,37 | 981 USD | |
| 2023-12-19 | 2023-12-15 | VP Vente planifiée |
Chief Medical Officer and EVP Dirigeant |
4 708
-3.5%
1,476 921 USD |
4 708 -3.5% | 1,47 | 6 921 USD | |
| 2023-12-19 | 2023-12-15 | V Vente |
CFO and COO Dirigeant |
6 747
-3.5%
1,479 918 USD |
6 747 -3.5% | 1,47 | 9 918 USD | |
| 2023-12-19 | 2023-12-15 | V Vente |
General Counsel Dirigeant |
1 476
-1.9%
1,472 170 USD |
1 476 -1.9% | 1,47 | 2 170 USD | |
| 2023-11-20 | 2023-11-16 | V Vente |
CFO and COO Dirigeant |
1 344
-0.7%
1,041 398 USD |
1 344 -0.7% | 1,04 | 1 398 USD | |
| 2023-11-20 | 2023-11-16 | V Vente |
Chief Medical Officer and EVP Dirigeant |
940
-0.8%
1,04978 USD |
940 -0.8% | 1,04 | 978 USD | |
| 2023-11-20 | 2023-11-16 | V Vente |
General Counsel Dirigeant |
1 722
-2.1%
1,041 791 USD |
1 722 -2.1% | 1,04 | 1 791 USD | |
| 2023-11-03 | 2023-11-01 | V Vente |
President and CEO Administrateur exécutif |
20 459
-9.1%
0,9319 027 USD |
20 459 -9.1% | 0,93 | 19 027 USD | |
| 2023-08-02 | 2023-07-31 | V Vente |
Chief Medical Officer and EVP Dirigeant |
485
-0.4%
2,261 096 USD |
485 -0.4% | 2,26 | 1 096 USD | |
| 2023-08-02 | 2023-07-31 | V Vente |
CFO and COO Dirigeant |
662
-0.3%
2,261 496 USD |
662 -0.3% | 2,26 | 1 496 USD | |
| 2023-06-21 | 2023-06-16 | V Vente |
Chief Medical Officer and EVP Dirigeant |
4 817
-3.7%
2,079 971 USD |
4 817 -3.7% | 2,07 | 9 971 USD | |
| 2023-06-21 | 2023-06-16 | V Vente |
CFO and COO Dirigeant |
6 904
-3.4%
2,0714 291 USD |
6 904 -3.4% | 2,07 | 14 291 USD | |
| 2023-06-21 | 2023-06-16 | V Vente |
General Counsel Dirigeant |
1 509
-1.8%
2,073 124 USD |
1 509 -1.8% | 2,07 | 3 124 USD | |
| 2023-05-19 | 2023-05-17 | V Vente |
Chief Medical Officer and EVP Dirigeant |
971
-0.7%
1,981 923 USD |
971 -0.7% | 1,98 | 1 923 USD | |
| 2023-05-19 | 2023-05-17 | V Vente |
General Counsel Dirigeant |
1 781
-2.1%
1,983 526 USD |
1 781 -2.1% | 1,98 | 3 526 USD | |
| 2023-05-19 | 2023-05-17 | V Vente |
CFO and COO Dirigeant |
1 389
-0.7%
1,982 750 USD |
1 389 -0.7% | 1,98 | 2 750 USD | |
| 2023-05-04 | 2023-05-02 | V Vente |
General Counsel Dirigeant |
5 102
-5.8%
2,2911 684 USD |
5 102 -5.8% | 2,29 | 11 684 USD | |
| 2023-03-21 | 2023-03-17 | V Vente |
CFO and COO Dirigeant |
3 945
-1.9%
2,8311 164 USD |
3 945 -1.9% | 2,83 | 11 164 USD | |
| 2023-03-21 | 2023-03-17 | V Vente |
Chief Medical Officer and EVP Dirigeant |
1 314
-1.0%
2,833 719 USD |
1 314 -1.0% | 2,83 | 3 719 USD | |
| 2023-02-02 | 2023-01-31 | V Vente |
Chief Financial Officer Dirigeant |
767
-0.4%
2,201 687 USD |
767 -0.4% | 2,20 | 1 687 USD | |
| 2023-02-02 | 2023-01-31 | V Vente |
Chief Medical Officer Dirigeant |
562
-0.4%
2,201 236 USD |
562 -0.4% | 2,20 | 1 236 USD | |
| 2022-12-22 | 2022-12-20 | V Vente |
Chief Medical Officer Dirigeant |
1 750
-1.3%
1,923 360 USD |
1 750 -1.3% | 1,92 | 3 360 USD | |
| 2022-12-22 | 2022-12-20 | V Vente |
Chief Financial Officer Dirigeant |
3 843
-1.8%
1,927 379 USD |
3 843 -1.8% | 1,92 | 7 379 USD | |
| 2022-12-19 | 2022-12-15 | V Vente |
Chief Financial Officer Dirigeant |
7 177
-3.3%
2,5017 943 USD |
7 177 -3.3% | 2,50 | 17 943 USD | |
| 2022-12-19 | 2022-12-15 | V Vente |
Chief Medical Officer Dirigeant |
7 177
-5.0%
2,5017 943 USD |
7 177 -5.0% | 2,50 | 17 943 USD | |
| 2022-12-19 | 2022-12-15 | V Vente |
General Counsel Dirigeant |
1 930
-2.1%
2,504 825 USD |
1 930 -2.1% | 2,50 | 4 825 USD | |
| 2022-12-06 | 2022-12-02 | V Vente |
Chief Medical Officer Dirigeant |
440
-0.3%
2,601 144 USD |
440 -0.3% | 2,60 | 1 144 USD | |
| 2022-12-06 | 2022-12-02 | V Vente |
Chief Financial Officer Dirigeant |
4 360
-2.0%
2,6011 336 USD |
4 360 -2.0% | 2,60 | 11 336 USD | |
| 2022-11-18 | 2022-11-16 | V Vente |
Chief Financial Officer Dirigeant |
1 294
-0.6%
2,713 507 USD |
1 294 -0.6% | 2,71 | 3 507 USD | |
| 2022-11-18 | 2022-11-16 | V Vente |
General Counsel Dirigeant |
2 045
-2.2%
2,715 542 USD |
2 045 -2.2% | 2,71 | 5 542 USD | |
| 2022-11-18 | 2022-11-16 | V Vente |
Chief Medical Officer Dirigeant |
1 295
-0.9%
2,713 509 USD |
1 295 -0.9% | 2,71 | 3 509 USD | |
| 2022-09-22 | 2022-09-20 | V Vente |
Chief Medical Officer Dirigeant |
1 581
-1.1%
3,485 502 USD |
1 581 -1.1% | 3,48 | 5 502 USD | |
| 2022-09-22 | 2022-09-20 | V Vente |
Chief Financial Officer Dirigeant |
3 474
-1.5%
3,4812 090 USD |
3 474 -1.5% | 3,48 | 12 090 USD | |
| 2022-09-08 | 2022-09-02 | V Vente |
Chief Medical Officer Dirigeant |
420
-0.3%
3,331 399 USD |
420 -0.3% | 3,33 | 1 399 USD | |
| 2022-09-08 | 2022-09-02 | V Vente |
Chief Financial Officer Dirigeant |
4 168
-1.8%
3,3313 879 USD |
4 168 -1.8% | 3,33 | 13 879 USD | |
| 2022-08-01 | 2022-07-28 | V Vente |
Chief Medical Officer Dirigeant |
632
-0.4%
3,912 471 USD |
632 -0.4% | 3,91 | 2 471 USD | |
| 2022-08-01 | 2022-07-28 | V Vente |
Chief Financial Officer Dirigeant |
632
-0.3%
3,912 471 USD |
632 -0.3% | 3,91 | 2 471 USD | |
| 2022-06-21 | 2022-06-17 | V Vente |
Chief Medical Officer Dirigeant |
1 565
-1.1%
3,295 149 USD |
1 565 -1.1% | 3,29 | 5 149 USD | |
| 2022-06-21 | 2022-06-17 | V Vente |
Chief Financial Officer Dirigeant |
3 440
-1.5%
3,2911 318 USD |
3 440 -1.5% | 3,29 | 11 318 USD | |
| 2022-06-17 | 2022-06-15 | V Vente |
Chief Financial Officer Dirigeant |
6 818
-2.8%
3,2422 090 USD |
6 818 -2.8% | 3,24 | 22 090 USD | |
| 2022-06-17 | 2022-06-15 | V Vente |
Chief Medical Officer Dirigeant |
6 818
-4.4%
3,2422 090 USD |
6 818 -4.4% | 3,24 | 22 090 USD | |
| 2022-06-17 | 2022-06-15 | V Vente |
General Counsel Dirigeant |
1 832
-2.4%
3,245 936 USD |
1 832 -2.4% | 3,24 | 5 936 USD | |
| 2022-06-06 | 2022-06-02 | V Vente |
Chief Financial Officer Dirigeant |
4 187
-1.7%
3,5915 031 USD |
4 187 -1.7% | 3,59 | 15 031 USD | |
| 2022-06-06 | 2022-06-02 | V Vente |
Chief Medical Officer Dirigeant |
421
-0.3%
3,591 511 USD |
421 -0.3% | 3,59 | 1 511 USD | |
| 2022-05-18 | 2022-05-16 | V Vente |
Chief Medical Officer Dirigeant |
1 286
-0.8%
4,866 250 USD |
1 286 -0.8% | 4,86 | 6 250 USD | |
| 2022-05-18 | 2022-05-16 | V Vente |
President and CEO Administrateur exécutif |
2 408
-0.6%
4,8611 703 USD |
2 408 -0.6% | 4,86 | 11 703 USD | |
| 2022-05-18 | 2022-05-16 | V Vente |
General Counsel Dirigeant |
664
-0.9%
4,863 227 USD |
664 -0.9% | 4,86 | 3 227 USD | |
| 2022-05-18 | 2022-05-16 | V Vente |
Chief Financial Officer Dirigeant |
1 286
-0.5%
4,866 250 USD |
1 286 -0.5% | 4,86 | 6 250 USD | |
| 2022-05-04 | 2022-05-02 | V Vente |
General Counsel Dirigeant |
5 733
-7.0%
5,5331 703 USD |
5 733 -7.0% | 5,53 | 31 703 USD | |
| 2022-04-15 | 2022-04-13 | V Vente |
President and CEO Administrateur exécutif |
64 430
0,000 USD |
64 430 | 0,00 | 0 USD | |
| 2022-03-04 | 2022-03-03 | A Achat |
Lightspeed Venture Partners Select IV, L.P. Affiliate of 10% Owner |
4 750
+inf%
10,3849 305 USD |
4 750 +inf% | 10,38 | 49 305 USD | |
| 2022-03-04 | 2022-03-03 | A Achat |
Lightspeed Venture Partners Select IV, L.P. Affiliate of 10% Owner |
261 011
+14.3%
9,832 565 738 USD |
261 011 +14.3% | 9,83 | 2 565 738 USD | |
| 2022-03-04 | 2022-03-02 | V Vente |
Chief Medical Officer Dirigeant |
471
-0.3%
10,184 795 USD |
471 -0.3% | 10,18 | 4 795 USD |